Deciphering UVA/Riboflavin Collagen Crosslinking: A Pathway to Improve Biomedical Materials
Advanced Functional Materials · 2024-08 · 34 (33)
DOI: 10.1002/adfm.202401742 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Functional Materials, online erschienen am 29.03.2024. Verfasst von Lu Fan und 9 weiteren Autor:innen. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 94 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: China Scholarship Council, Bundesministerium für Bildung und Forschung.
Abstract (Originalsprache)
Collagen crosslinking employing ultraviolet A rays and riboflavin (UVA/R) has emerged as a pivotal technique in clinical therapies, especially in ophthalmology since the 1990s. Despite its clinical adoption, the lack of clarity of the detailed mechanism and the imperative for a refined manufacturing process necessitates further investigation. This study advances the understanding of UVA/R crosslinked collagen, concentrating on identifying the primary crosslinking sites using seven synthetic peptides and exploring the pathways of riboflavin‐mediated crosslinking. The results demonstrate that tyrosine residues are key crosslinking sites, and riboflavin plays a dual role as both a catalyst and a competitive inhibitor in the crosslinking process. Furthermore, the UVA/R crosslinked collagen matrix exhibits a more harmonious balance between stability and degradability compared with chemically crosslinked collagen matrices, coupled with superior mechanical properties and augmented biocompatibility. In vivo experiments further validate its excellent biocompatibility, reduced tissue inflammation, and promotion of tissue regeneration. The research provides crucial insights into collagen crosslinking mechanisms, paving the way for the development of sophisticated collagen‐based biomaterials tailored for biomedical applications.
Förderung
- China Scholarship Council
- Bundesministerium für Bildung und Forschung
Zitieren
APA
Fan, L., Jung, O., Herrmann, M., Shirokikh, M., Stojanovic, S., Najman, S., Körte, F., Xiong, X., Schenke‐Layland, K., & Barbeck, M. (2024). Deciphering UVA/Riboflavin Collagen Crosslinking: A Pathway to Improve Biomedical Materials. Advanced Functional Materials, 34(33). https://doi.org/10.1002/adfm.202401742
Vancouver
Fan L, Jung O, Herrmann M, Shirokikh M, Stojanovic S, Najman S, et al. Deciphering UVA/Riboflavin Collagen Crosslinking: A Pathway to Improve Biomedical Materials. Advanced Functional Materials. 2024;34(33). doi:10.1002/adfm.202401742
BibTeX
@article{Fan2024,
author = {Fan, Lu and Jung, Ole and Herrmann, Markus and Shirokikh, Marina and Stojanovic, Sanja and Najman, Stevo and Körte, Fabian and Xiong, Xin and Schenke‐Layland, Katja and Barbeck, Mike},
title = {Deciphering UVA/Riboflavin Collagen Crosslinking: A Pathway to Improve Biomedical Materials},
journal = {Advanced Functional Materials},
year = {2024},
volume = {34},
number = {33},
doi = {10.1002/adfm.202401742}
}
EUVIMED